Related Experiment Video
Updated: Feb 3, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
The gut microbiome of Mexican children affected by obesity
Otoniel Maya-Lucas1, Selvasankar Murugesan1, Khemlal Nirmalkar2
1Departamento de Genética y Biología Molecular, Cinvestav Unidad Zacatenco, Av IPN 2508, Ciudad de México 07360, Mexico.
Insights
Mexican children
Area of Science:
- Microbiome research
- Pediatric obesity
- Metabolic disorders
Background:
- Obesity is a significant global health concern, particularly in Mexico where over a third of children aged 5-11 are overweight or obese.
- Understanding the gut microbiome's role in pediatric obesity is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the gut microbiome composition and its association with metabolic factors in obese Mexican children.
- To identify specific microbial alterations linked to obesity in this pediatric cohort.
Main Methods:
- Metagenomic shotgun sequencing of fecal DNA from normal weight and obese Mexican children.
- Analysis of metabolic factors and fecal short-chain fatty acids.
- Enterotyping and comparative metabolic pathway analysis.
Main Results:
- Obese children showed an increase in unclassified Methanobrevibacter spp. and over-representation of Megamonas spp.
- Gut bacterial communities were characterized by enterotypes, with Prevotella spp. dominating in obese children and Ruminococcus spp. in normal weight children.
- Depletion of Oscillospiraceae family members in obese children correlated negatively with serum cholesterol levels. Glycolysis pathways were overrepresented in normal weight children.
Conclusions:
- Specific gut microbiome alterations are associated with obesity in Mexican children.
- Microbiome composition can be correlated with clinical metadata, potentially aiding in stratification and identifying biomarkers.
- Findings offer insights for the prognosis, diagnosis, and treatment of pediatric obesity through microbiome modulation.
Abstract:
Obesity is a metabolic disorder and global health issue. In Mexico 34.4% of children between 5 and 11 years-old are overweight or obese. Here we address this issue studying the gut microbiome in a sample of Mexican children affected by obesity. We performed metagenomic shotgun-sequencing of DNA isolated from fecal samples from a cohort of normal weight and obese Mexican children using Illumina platform with HiSeq 2500. We also examined their metabolic factors and fecal short-chain fatty acids concentration. The results show that a remarkable dysbiosis of bacteria, archaea and viruses was not observed in the obese children group compared to the normal weight group; however, the archaeal community exhibited an increase of unclassified Methanobrevibacter spp. in obese children. The bacterial communities of all participants were clustered into three different enterotypes. Most normal weight children have a gut bacterial community dominated by Ruminococcus spp. (Enterotype 3), while most obese children had a community dominated by Prevotella spp. (Enterotype 2). On the other hand, changes in the gut microbiome were correlated with clinical metadata and could be used to stratify individuals based on their phenotype. The species Megamonas spp. were over-represented in obese children, whereas members of the family Oscillospiraceae were depleted in the same individuals and negatively correlated with levels of serum cholesterol. A microbiome comparative metabolic pathway analysis showed that two KEGG pathway modules of glycolysis, Glycolysis I (from Glucose 6-Phosphate), and Glycolysis II (from Fructose 6-Phosphate) were significantly overrepresented in normal weight children. Our results establish specific alterations in the gut microbiome of Mexican children affected of obesity, along with clinical alterations, providing information on the microbiome composition that may be useful for prognosis, diagnosis, and treatment.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Drug Dosing: Infants and Children
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Physiology of Enteric Nervous System and Gut Health

